Rockwell Medical (RMTI) Projected to Post Earnings on Thursday

Rockwell Medical (NASDAQ:RMTI) is expected to be announcing its earnings results before the market opens on Thursday, March 20th. Analysts expect the company to announce earnings of $0.02 per share and revenue of $23.65 million for the quarter. Investors that are interested in registering for the company’s conference call can do so using this link.

Rockwell Medical Stock Performance

Rockwell Medical stock opened at $1.77 on Tuesday. The firm’s fifty day moving average price is $1.90 and its 200-day moving average price is $2.64. The company has a debt-to-equity ratio of 0.33, a quick ratio of 2.00 and a current ratio of 2.41. The stock has a market cap of $57.20 million, a P/E ratio of -35.40 and a beta of 1.55. Rockwell Medical has a fifty-two week low of $1.36 and a fifty-two week high of $5.15.

Wall Street Analysts Forecast Growth

Several analysts have recently weighed in on RMTI shares. StockNews.com cut shares of Rockwell Medical from a “buy” rating to a “hold” rating in a research report on Friday, December 20th. HC Wainwright reaffirmed a “buy” rating and set a $7.00 target price on shares of Rockwell Medical in a report on Monday, December 23rd.

About Rockwell Medical

Rockwell Medical, Inc, together with its subsidiaries, operates as a healthcare company that engages in the development, manufacture, commercialization, and distribution of various hemodialysis products for dialysis providers worldwide. The company offers Triferic Dialysate and Triferic AVNU which are indicated to maintain hemoglobin in adult undergoing hemodialysis.